Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Updates in HR+ Advanced Breast Cancer
11
Mins
July 2025
The therapeutic landscape for hormone receptor-positive (HR+) advanced breast cancer (BC) is moving from generalized endocrine therapies…
Read more
11
Mins
15 Jul 2025
Updates in HR+ Advanced Breast Cancer
The therapeutic landscape for hormone receptor-positive (HR+) advanced breast cancer (BC) is moving from generalized endocrine therapies…
9
Mins
15 Jul 2025
Enhancing Cancer Care Through Vaccines
Patients with cancer often have a compromised immune system, which places them at an increased risk of infection that can extend beyond…
4
Mins
15 Jul 2025
Advances in HER2-Mutant NSCLC
Mutations in HER2, also known as ERBB2, represent a distinct molecular subset of NSCLC, occurring in approximately 2–4% of cases, and are…
2
Mins
15 Jul 2025
Targeting DLL3 in Rare Neuroendocrine Carcinoma
EpNECs are considered rare and are often associated with a poor prognosis, with up to 85% of patients presenting with advanced…
10
Mins
15 Jul 2025
The Two Faces of Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is frequently diagnosed at an advanced stage, when most patients have underlying cirrhosis. Prognosis is…
14
Mins
15 Jul 2025
Neoadjuvant Therapy in TNBC
Triple-negative breast cancer (TNBC) comprises 10–15% of all breast cancers. It is a very heterogeneous disease, characterized by the…
15
Mins
15 Jul 2025
Current Approaches to Recurrent and Metastatic Cervical Cancer
Despite improved screening and treatment in developing nations, cervical cancer continues to have a global incidence of approximately…
11
Mins
15 Jul 2025
High-Grade Gallbladder Neuroendocrine Tumor in a Young Female
Neuroendocrine tumors (NET) constitute a heterogeneous group of neoplasms that originate from cells of the diffuse neuroendocrine system…
Loading posts...
1
2
3
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View